DFCM
VKTX icon

Dark Forest Capital Management’s Viking Therapeutics VKTX Stock Holding History

Dark Forest Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-47,423
Closed -$1.67M – 1161
2025
Q4 		$1.67M Buy
+47,423
New +$1.68M 0.08% 456
2022
Q2 		– Sell
-1,878
Closed -$6K – 1397
2022
Q1 		$6K Buy
+1,878
New +$6.74K ﹤0.01% 1094
2021
Q4 		– Sell
-2,737
Closed -$17K – 1796
2021
Q3 		$17K Buy
2,737
+2,081
+317% +$12.9K 0.01% 875
2021
Q2 		$4K Buy
+656
New +$3.9K ﹤0.01% 724

Other funds holding VKTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dark Forest Capital Management's VKTX Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Viking Therapeutics (VKTX) in Q1 2026, closing a stake of 47,423 shares — an estimated $1.67M sold.

Dark Forest Capital Management first reported a position in VKTX in Q2 2021 and held it in 4 quarters. The position peaked at $1.67M in Q4 2025. 414 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Viking Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 47,423 Viking Therapeutics shares in Q1 2026, an estimated $1.67M.
  • Dark Forest Capital Management first reported a position in Viking Therapeutics in Q2 2021 and held it in 4 quarters.
  • Dark Forest Capital Management's Viking Therapeutics position peaked at $1.67M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.